Table 4. Univariate and multivariate analysis of prognostic parameters for survival in patients with CRC.
| Prognostic parameter | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| Expression of NOX4 (high vs. low) | 3.342 (1.679–6.652) | 0.001* | 2.919 (1.382–6.163) | 0.005* |
| Age (< 65 vs. ≥ 65) | 1.186 (0.643–2.186) | 0.585 | – | – |
| Sex (male vs. female) | 1.310 (0.702–2.443) | 0.396 | – | – |
| Tumor location (right hemicolon vs. left hemicolon) | 0.862 (0.472–1.574) | 0.629 | – | – |
| Tumor size (< 5 cm vs. ≥ 5 cm) | 2.218 (1.155–4.259) | 0.017* | 2.158 (1.101–4.231) | 0.025* |
| T classification (T1 vs. T2 vs. T3 vs. T4) | 1.723 (1.007–2.949) | 0.047* | 0.967 (0.562–1.663) | 0.903 |
| Lymph node metastasis (Absent vs. Present) | 1.707 (0.931–3.130) | 0.084 | – | – |
| Distant metastasis (Absent vs. Present) | 5.269 (2.307–12.033) | 0.000* | 3.209 (1.321–7.799) | 0.010* |
| Tumor differentiation (Well/moderate vs. poor) | 1.475 (0.769–2.831) | 0.242 | – | – |
The bold number indicates the P-values with statistical significance. HR: Hazard ratio; CI: Confidence interval.